Dr. Jonathan E. Noonan, MD

Dr. Noonan practices at Lehigh Valley Eye Center in Garden City, New York.

Dr. Noonan's NPI, 1518654391, was assigned on April 20, 2023. Dr. Noonan holds Pennsylvania license MD484013.

Dr. Noonan's primary practice is Lehigh Valley Eye Center, at 825 E Gate Blvd, Garden City, NY 11530 in Nassau County. The practice phone is (610) 776-7400.

Dr. Noonan's primary practice is Lehigh Valley Eye Center in Garden City, New York. Dmand AI also links Dr. Noonan to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Noonan practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Noonan's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Noonan is licensed in Pennsylvania.

CMS data shows 4,585 Medicare services from Dr. Noonan across 8 procedure codes in 2024, for 158 Medicare patients. Medicare paid $317,624 for them. Every service was in an office.

CMS counts 158 Medicare patients who saw Dr. Noonan in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Noonan's median patient age at 74, with 58% women.

In 2024, Dr. Noonan wrote 227 Medicare Part D claims for 79 patients. 50% of them were for generic drugs. CMS names the drug for 160 of them, across 7 drugs with 11 or more claims each, at $4,855 in total drug cost.

Dr. Noonan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 33 general payments to Dr. Noonan from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Apellis Pharmaceuticals, Inc. paid the most, $239.